Performance of ARGX argenx NV ADR | 0.2% in 12m
Compare ARGX with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare argenx NV ADR with its related Sector/Index XBI
Performance Duell ARGX vs XBI
| TimeFrame | ARGX | XBI |
|---|---|---|
| 1 Day | 2.63% | 1.16% |
| 1 Week | 6.73% | 7.44% |
| 1 Month | -0.93% | -2.58% |
| 3 Months | 3.85% | 0.42% |
| 6 Months | -20.1% | 29.44% |
| 12 Months | 0.16% | 10.82% |
| YTD | 3.26% | -2.09% |
| Rel. Perf. 1m | 0.22 | |
| Rel. Perf. 3m | -2.03 | |
| Rel. Perf. 6m | -4.74 | |
| Rel. Perf. 12m | -0.76 |
Is argenx NV ADR a good stock to buy?
No, based on ValueRay Fundamental Analyses, argenx NV ADR (NASDAQ:ARGX) is currently (May 2024)
a stock to sell. It has a ValueRay Fundamental Rating of -54.88 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ARGX as of May 2024 is 471.99. This means that ARGX is currently undervalued and has a potential upside of +19.97% (Margin of Safety).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ARGX as of May 2024 is 471.99. This means that ARGX is currently undervalued and has a potential upside of +19.97% (Margin of Safety).
Is ARGX a buy, sell or hold?
- Strong Buy: 13
- Buy: 6
- Hold: 4
- Sell: 0
- Strong Sell: 0
Values above 0%: ARGX is performing better - Values below 0%: ARGX is underperforming
Compare ARGX with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 6.42% | 1.73% | -38.16% | -24.55% |
| US NASDAQ 100 | QQQ | 6.15% | 2.29% | -37.99% | -34.40% |
| US Dow Jones Industrial 30 | DIA | 6.39% | 1.42% | -34.09% | -15.50% |
| German DAX 40 | DBXD | 6.92% | 1.35% | -37.93% | -12.98% |
| UK FTSE 100 | ISFU | 5.45% | -3.65% | -34.63% | -9.39% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 1.80% | -4.28% | -24.71% | 10.11% |
| Hongkong Hang Seng | HSI | -0.14% | -7.13% | -20.58% | 14.63% |
| Japan Nikkei 225 | EXX7 | 4.37% | 4.43% | -33.95% | -19.64% |
| India NIFTY 50 | INDA | 5.41% | -3.66% | -40.96% | -29.12% |
| Brasil Bovespa | EWZ | 3.58% | -0.21% | -24.41% | -23.22% |
ARGX argenx NV ADR vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 4.92% | 2.47% | -39.98% | -36.13% |
| Consumer Discretionary | XLY | 5.36% | 0.80% | -32.37% | -21.36% |
| Consumer Staples | XLP | 6.86% | -1.31% | -31.90% | -0.58% |
| Energy | XLE | 10.94% | 3.09% | -27.67% | -18.78% |
| Financial | XLF | 7.76% | 1.97% | -42.49% | -27.22% |
| Health Care | XLV | 6.33% | 1.64% | -31.78% | -6.68% |
| Industrial | XLI | 7.17% | 1.07% | -42.18% | -24.44% |
| Materials | XLB | 7.11% | 3.08% | -35.55% | -13.29% |
| Real Estate | XLRE | 5.91% | 3.44% | -29.04% | -3.32% |
| Technology | XLK | 7.00% | 3.80% | -36.44% | -32.72% |
| Utilities | XLU | 5.31% | -4.77% | -32.40% | -2.69% |
| Aerospace & Defense | XAR | 3.90% | -1.95% | -35.83% | -20.92% |
| Biotech | XBI | -0.71% | 1.65% | -49.52% | -10.66% |
| Homebuilder | XHB | 5.70% | 3.08% | -57.84% | -48.34% |
| Retail | XRT | 6.34% | 4.00% | -41.03% | -20.85% |
Does argenx NV ADR outperform its market, is ARGX a Sector Leader?
No, over the last 12 months argenx NV ADR (ARGX) made 0.16%, while its related Sector, the SPDR S&P Biotech (XBI) made 10.82%.
Over the last 3 months ARGX made 3.85%, while XBI made 0.42%.
No, over the last 12 months argenx NV ADR (ARGX) made 0.16%, while its related Sector, the SPDR S&P Biotech (XBI) made 10.82%.
Over the last 3 months ARGX made 3.85%, while XBI made 0.42%.
| Period | ARGX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -0.93% | -2.58% | -2.66% |
| 3 Months | 3.85% | 0.42% | 2.48% |
| 12 Months | 0.16% | 10.82% | 24.71% |